Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Béla, Pikó"'
Autor:
Gábor Rubovszky, Judit Kocsis, Katalin Boér, Nataliya Chilingirova, Magdolna Dank, Zsuzsanna Kahán, Dilyara Kaidarova, Erika Kövér, Bibiana Vertáková Krakovská, Károly Máhr, Bela Mriňáková, Béla Pikó, Ivana Božović-Spasojević, Zsolt Horváth
Publikováno v:
Pathology and Oncology Research, Vol 29 (2023)
Externí odkaz:
https://doaj.org/article/38ca331fd71f426c971a98d8d9f4302e
Autor:
Gábor Rubovszky, Judit Kocsis, Katalin Boér, Nataliya Chilingirova, Magdolna Dank, Zsuzsanna Kahán, Dilyara Kaidarova, Erika Kövér, Bibiana Vertáková Krakovská, Károly Máhr, Bela Mriňáková, Béla Pikó, Ivana Božović-Spasojević, Zsolt Horváth
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
This text is based on the recommendations accepted by the 4th Hungarian Consensus Conference on Breast Cancer, modified based on the international consultation and conference within the frames of the Central-Eastern European Academy of Oncology. The
Externí odkaz:
https://doaj.org/article/2f635a7fa78e4bceae1f304dd5715ff7
Autor:
Róbert János Bánhegyi, Blanka Veréb, Andrea Gazdag, Beatrix Rácz, Róbert Wagner, Norbert Fülöp, Béla Pikó
Publikováno v:
Orvosi Hetilap. 163:1614-1628
A rosszindulatú daganatok és a diabetes mellitus epidemiológiai mutatói hasonlóan változnak, vagyis a világban a rák- és a cukorbetegek száma egyaránt dinamikusan növekszik. A közös metabolikus és molekuláris háttérrel is magyarázh
Autor:
Yutaka Yamamoto, Hiroyasu Yamashiro, Andreas Schneeweiss, Volkmar Müller, Oleg Gluz, Peter Klare, Bahriye Aktas, Dank Magdolna, László Büdi, Béla Pikó, László Mangel, Masakazu Toi, Satoshi Morita, Shinji Ohno
Publikováno v:
Breast Cancer. 30:88-100
Background Bevacizumab (BV) plus paclitaxel (PTX) is a treatment option in patients with HER2-negative metastatic breast cancer (mBC). We conducted an international pooled analysis with individual patient data to evaluate the effectiveness of BV + PT
The neuoroendocrine cancer of the bladder is a rare tumour, and from this entity the well-differentiated tumours with favourable prognosis, the paraganglioma with unfavourable prognosis, small and large cell types of tumours should be emphasised. Fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87698bf5012f162ae1a9bb0f87f46f55
https://doi.org/10.5772/intechopen.106461
https://doi.org/10.5772/intechopen.106461
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zsolt, Horváth, Katalin, Boér, Magdolna, Dank, Zsuzsanna, Kahán, Judit, Kocsis, Erika, Kövér, Károly, Máhr, Béla, Pikó, Gábor, Rubovszky
Publikováno v:
Magyar onkologia. 64(4)
Since the III. Breast Cancer Consensus Conference, a number of new evidence based on clinical trial results have been published which justified updating the 2016 recommendation. In addition to classical prognostic factors, some multigenic tests, whic
Publikováno v:
Magyar onkologia. 65(1)
The protection of the veins in patients with malignancies is of high importance (regarding both blood taking and the drug administration). In order to prevent any unnecessary injury, every phlebotomy needs to have a sophisticated indication and requi
Publikováno v:
Magyar Onkologia; 2021, Vol. 65 Issue 4, p355-358, 4p
Publikováno v:
Nővér; 2021, Vol. 34 Issue 1, p34-39, 6p